II. Indications
- Acute Gastrointestinal Bleeding
-
Colon Cancer screening
- Start Occult blood screening by age 50 years old (or per Colorectal Cancer Screening protocol)
III. Preparations
- Guaiac-Based Test (gFOBT, Hemoccult)
- Reagent derived from wood resin of Guajacum trees
- Reaction based on presence of Hemoglobin in sample
- Hemoglobin contains pseudoperoxidase
- Pseudoperoxidase converts guaiac to blue
- Reaction requires addition of Hydrogen Peroxide
- Most commonly used test (for both GI Bleeding, Colorectal Cancer Screening)
- Do not use office based testing for screening
- Efficacy for gFOBT in Colorectal Cancer Screening (based on 3 home samples submitted)
- Test Sensitivity: 62-79%
- Test Specificity: 87-96%
- Positive Likelihood Ratio: 4.7 to 19.8
- Negative Likelihood Ratio: 0.2 to 0.4
- Holme (2013) Cochrane Database Syst Rev (9):CD009259 [PubMed]
- Fecal Immunochemical Test (FIT, HemeSelect, FECA-EIA, OC-Micro, OC-Sensor, OC-Light)
- Identifies only intact human Hemoglobin
- Efficacy in screening for Colorectal Cancer
- Advantages
- Ingested red meat does not give False Positive
- Food-based peroxidases do not give False Positives
- Specific for lower Gastrointestinal Tract bleeding
- Disadvantages
- Requires increased lab staff time
- Detects only lower Gastrointestinal Tract bleeding
- Fecal Immunochemical with DNA Test or Multitarget Stool DNA Test (FIT-DNA, ColoGuard)
- Combination of FIT testing (see above) and DNA biomarkers
- Detects Hemoglobin (as does FIT)
- Detects Colorectal Cancer and precancer related DNA mutations and methylations
- Much more expensive than FIT Testing alone ($680 vs $70)
- Efficacy in screening for Colorectal Cancer
- Test Sensitivity: 92%
- Far more sensitive than FIT Testing (74% sensitive)
- Test Specificity: 87 to 90%
- Less specific (more False Positives) than FIT Testing (95% specific)
- Test Sensitivity: 92%
- References
- Combination of FIT testing (see above) and DNA biomarkers
- Heme-Porphyrin Test (Hemoquant)
- Quantifies Porphyrins from Hemoglobin
- Advantages
- Measures amount of stool blood present
- Food-based peroxidases do not give False Positives
- Disadvantages
- Expensive and requires increased lab staff time
- High False Positive Rate
IV. Efficacy: Colon Cancer Screening (Guaiac tests)
- USPSTF Strength of Recommendation: B
- Screening picks up 26% of Colorectal Cancer
- Lowers Colon Cancer mortality (versus no screening)
- Annual screening: 33% reduction
- Biennial (every 2 years): 15-21% reduction
- References
V. Technique: Guaiac tests (Hemoccult)
- Use high-sensitivity guaiac-based tests (Hemoccult Sensa)
- Minimize False Positive Rate
- See False Positives below
- Avoid listed items for 3 days prior to testing
- Aspirin and NSAIDs appear to be safe prior to FOBT
- (2005) Prescriber's Letter p. 15
- Minimize False Negative Rate
- Avoid Vitamin C >250 mg/day for 2 days before test
- Test 2 samples from each of 3 consecutive stools
- Space samples over 4-6 days
- Digital Rectal Exam does not increase False Positives
VI. Causes: False Positive Guaiac tests (Hemoccult)
- Foods associated with False Positive FOBT
- Common Causes
- Red meat
- Cantaloupe and other melon
- Grapefruit
- Figs
- Broccoli
- Turnips
- Radishes
- Horseradish
- Cauliflower
- Uncommon causes of False Positive FOBT
- Cucumber
- Carrot
- Cabbage
- Potato
- Pumpkin
- Zucchini
- Parsley
- Common Causes
- Medications and Supplements
- Previously ASA NSAIDS thought to cause False Positive
- Now both are thought to be safe prior to FOBT
- Avoid doses of ASA >1250 mg/day
- Medications that do not result in False Positives
- Previously ASA NSAIDS thought to cause False Positive
- Miscellaneous causes of False Positive FOBT
- Nasal bleeding source (e.g. Epistaxis)
- Oral Bleeding source
- Pulmonary bleeding source (e.g. Hemoptysis)
- Long distance Running
VII. Causes: Positive occult blood test
VIII. References
- Rockey in Feldman (2002) Sleisenger GI, p. 232-48
- Herold in Rakel (2002) Family Practice, p. 1563-4
- Wilkins (2018) Am Fam Physician 97(10): 658-65 [PubMed]